T‐T. Pelliniemi

Immunoreactive interleukin-6 and acute phase proteins as prognostic factors in multiple myeloma. Finnish Leukemia Group

T‐T. Pelliniemi, Kerttu Irjala, Kari Mattila et al. · Blood · 1995 · 135 citations · Full text

Medicine, Immunology, Oncology +12

Low-dose or intermediate-dose cyclophosphamide plus granulocyte colony-stimulating factor for progenitor cell mobilisation in patients with multiple myeloma

Esa Jantunen, Matti Putkonen, T. Nousiainen et al. · Bone Marrow Transplantation · 2003 · 76 citations

Medicine, Hematology, Oncology +17

Febrile infection changes the expression of IgG Fc receptors and complement receptors in human neutrophils <i>in vivo</i>

L. Leino, Katja Sorvajärvi, Johanna Katajisto et al. · Clinical & Experimental Immunology · 1997 · 65 citations · Full text

Life Sciences, Immunology, Microbiology +17

Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group

Erkki Elonen, A. Almqvist, A. Hänninen et al. · Leukemia · 1998 · 49 citations

Medicine, Oncology, Chemotherapy +9

Comparative analysis of minimal residual disease detection by multiparameter flow cytometry and enhanced ASO RQ-PCR in multiple myeloma

Raija Silvennoinen, Tuija Lundán, Veli Kairisto et al. · Blood Cancer Journal · 2014 · 37 citations · Full text

Medicine, Hematology, Cancer Immunology +13